FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385145438> ?p ?o ?g. }

• W4385145438 endingPage "112" @default.
• W4385145438 startingPage "105" @default.
• W4385145438 abstract "Because of its anatomic and procedural complexities, bicuspid aortic valve (BAV) has been excluded from previous trials investigating transcatheter aortic valve replacement (TAVR). We aimed to compare the clinical outcomes of TAVR in BAV and tricuspid aortic valve patients. We searched the databases systematically from inception until March 2023 for studies that reported the outcomes of TAVR in BAV and tricuspid aortic valve patients. The primary focus was all-cause mortality at 1 year. Additional outcomes included outcomes at 30-day follow-up. Secondary and subgroup analyses were performed on propensity-matched patients, patients at low surgical risk, and based on the type of transcatheter valve type. We included 30 studies with a total of 193,274 patients who underwent TAVR, of which 14,353 patients had BAV stenosis. The rate of 1-year mortality was lower in the BAV group compared with the tricuspid group with the results reaching statistical significance (odds ratio [OR] 0.86, 95% confidence interval [CI] 0.75 to 0.98, p = 0.02). The rate of 30-day stroke, however, was higher in patients with BAV who underwent TAVR (OR 1.24, 95% CI 1.08 to 1.43, p <0.05). Other 30-day clinical outcomes were similar between the 2 groups. Similar outcomes were observed in secondary analysis of matched populations with less mortality and higher rate of stroke in patients with BAV (OR 0.84, 95% CI 0.72 to 0.96, p = 0.01, and OR 1.38, 95% CI 1.09 to 1.75, p <0.05, respectively). Comparing the outcomes for self-expandable and balloon-expandable valves resulted in similar results. Subgroup analysis of low-surgical-risk patients similarly showed lower 1-year mortality in patients with BAV (OR 0.67, 95% CI 0.50 to 0.91, p = 0.01), without difference in 30-day stroke between the 2 groups (OR 1.24, 95% CI 0.83 to 1.88, p = 0.30). In conclusion, this report indicates that TAVR is safe and feasible in patients with BAV, including patients at low surgical risk. The higher rate of 30-day stroke, however, warrants caution when pursuing TAVR in this population. More studies, specifically randomized trials, are still warranted to further assess the safety and the long-term outcomes in this group." @default.
• W4385145438 created "2023-07-23" @default.
• W4385145438 creator A5010534951 @default.
• W4385145438 creator A5014682224 @default.
• W4385145438 creator A5023811312 @default.
• W4385145438 creator A5029785552 @default.
• W4385145438 creator A5036517112 @default.
• W4385145438 creator A5037909908 @default.
• W4385145438 creator A5050833312 @default.
• W4385145438 creator A5055905978 @default.
• W4385145438 creator A5064077583 @default.
• W4385145438 creator A5090599338 @default.
• W4385145438 date "2023-09-01" @default.
• W4385145438 modified "2023-10-11" @default.
• W4385145438 title "Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Aortic Valve Stenosis: Meta-Analysis and Systemic Review" @default.
• W4385145438 cites W1956430362 @default.
• W4385145438 cites W2031630663 @default.
• W4385145438 cites W2033687467 @default.
• W4385145438 cites W2087967794 @default.
• W4385145438 cites W2102129596 @default.
• W4385145438 cites W2121967184 @default.
• W4385145438 cites W2134833483 @default.
• W4385145438 cites W2482392026 @default.
• W4385145438 cites W2531269403 @default.
• W4385145438 cites W2586276406 @default.
• W4385145438 cites W2595545849 @default.
• W4385145438 cites W2740120589 @default.
• W4385145438 cites W2767486149 @default.
• W4385145438 cites W2773169111 @default.
• W4385145438 cites W2781562654 @default.
• W4385145438 cites W2805518505 @default.
• W4385145438 cites W2809415387 @default.
• W4385145438 cites W2887602151 @default.
• W4385145438 cites W2901532802 @default.
• W4385145438 cites W2905609438 @default.
• W4385145438 cites W2912273977 @default.
• W4385145438 cites W2914235646 @default.
• W4385145438 cites W2916914732 @default.
• W4385145438 cites W2950068502 @default.
• W4385145438 cites W2955739149 @default.
• W4385145438 cites W3005209398 @default.
• W4385145438 cites W3006901445 @default.
• W4385145438 cites W3028821063 @default.
• W4385145438 cites W3041936932 @default.
• W4385145438 cites W3050103316 @default.
• W4385145438 cites W3106930251 @default.
• W4385145438 cites W3120447146 @default.
• W4385145438 cites W3200052416 @default.
• W4385145438 cites W3202186128 @default.
• W4385145438 cites W4220791470 @default.
• W4385145438 cites W4220949192 @default.
• W4385145438 cites W4309740540 @default.
• W4385145438 cites W4311125278 @default.
• W4385145438 cites W4313574845 @default.
• W4385145438 cites W53141608 @default.
• W4385145438 doi "https://doi.org/10.1016/j.amjcard.2023.06.120" @default.
• W4385145438 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37487404" @default.
• W4385145438 hasPublicationYear "2023" @default.
• W4385145438 type Work @default.
• W4385145438 citedByCount "0" @default.
• W4385145438 crossrefType "journal-article" @default.
• W4385145438 hasAuthorship W4385145438A5010534951 @default.
• W4385145438 hasAuthorship W4385145438A5014682224 @default.
• W4385145438 hasAuthorship W4385145438A5023811312 @default.
• W4385145438 hasAuthorship W4385145438A5029785552 @default.
• W4385145438 hasAuthorship W4385145438A5036517112 @default.
• W4385145438 hasAuthorship W4385145438A5037909908 @default.
• W4385145438 hasAuthorship W4385145438A5050833312 @default.
• W4385145438 hasAuthorship W4385145438A5055905978 @default.
• W4385145438 hasAuthorship W4385145438A5064077583 @default.
• W4385145438 hasAuthorship W4385145438A5090599338 @default.
• W4385145438 hasConcept C126322002 @default.
• W4385145438 hasConcept C127413603 @default.
• W4385145438 hasConcept C156957248 @default.
• W4385145438 hasConcept C164705383 @default.
• W4385145438 hasConcept C179755657 @default.
• W4385145438 hasConcept C2776570981 @default.
• W4385145438 hasConcept C2779946567 @default.
• W4385145438 hasConcept C2780007028 @default.
• W4385145438 hasConcept C2780026749 @default.
• W4385145438 hasConcept C2780645631 @default.
• W4385145438 hasConcept C2780714102 @default.
• W4385145438 hasConcept C2781355080 @default.
• W4385145438 hasConcept C2781414266 @default.
• W4385145438 hasConcept C44249647 @default.
• W4385145438 hasConcept C71924100 @default.
• W4385145438 hasConcept C78519656 @default.
• W4385145438 hasConceptScore W4385145438C126322002 @default.
• W4385145438 hasConceptScore W4385145438C127413603 @default.
• W4385145438 hasConceptScore W4385145438C156957248 @default.
• W4385145438 hasConceptScore W4385145438C164705383 @default.
• W4385145438 hasConceptScore W4385145438C179755657 @default.
• W4385145438 hasConceptScore W4385145438C2776570981 @default.
• W4385145438 hasConceptScore W4385145438C2779946567 @default.
• W4385145438 hasConceptScore W4385145438C2780007028 @default.
• W4385145438 hasConceptScore W4385145438C2780026749 @default.
• W4385145438 hasConceptScore W4385145438C2780645631 @default.
• W4385145438 hasConceptScore W4385145438C2780714102 @default.

• next